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A variety of model biopolymers, including oligonucleotides, oligosaccharides and a synthetic
pharmaceutical agent, were sequenced using a triple quadrupole mass spectrometer equipped
with an electrospray source and operated in a scan mode referred to as pseudo-MS3. This scan
mode consists of three steps: (1) in-source collision-induced dissociation (CID) in the
nozzle-skimmer (NS) region, (2) scanning of the fragment ions into the collision cell for further
CID, and (3) passing of the secondary fragment ions through the final mass filter at a
preselected mass, generally corresponding to the mass of a terminal sequence ion for the
biopolymer. The mass spectra are recorded in the precursor ion MS/MS mode where ion
selection and detection occur at the third stage of the triple quadrupole but the scan function
is determined by the first stage. The advantages and limitations in using this pseudo-MS3
NS/precursor ion MS/MS scan mode for biopolymer sequencing are discussed. (J Am Soc
Mass Spectrom 2001, 12, 846–852) © 2001 American Society for Mass Spectrometry
Mass spectrometry has been used widely for thesequencing of biopolymers, viz., peptides[1–3], oligonucleotides [4–6] and oligosaccha-
rides [7, 8]. The extraction of sequence information from
the mass spectra of biopolymers is often performed by
correlating all the ions produced in the product ion
MS/MS mode using sequencing algorithms. Recently,
multiple-stage mass analysis (MSn), using trapping in-
struments such as a Fourier transform mass spectrom-
eter (FTMS) [9, 10] or quadrupole ion trap [7], have
proved very useful for obtaining sequence information.
However, compared to FTMS and quadrupole ion trap
instruments, tandem mass spectrometry has been more
widely practiced in the past utilizing triple quadrupole
analyzers in the MS/MS mode. To simplify the peptide
sequencing process, terminal groups of peptides are
often labeled by derivatization [11, 12] and/or isotopic
exchange [13] to identify all fragment ions associated
with that terminal group. In addition, strategies involv-
ing more than one step of collision-induced dissociation
(CID) have been applied for extracting information
about product/precursor relationships from the gener-
ated mass spectra. Cooks and coworkers have reported
MS3 experiments using electron impact (EI) and chem-
ical ionization (CI) sources with hybrid BEQQ and
pentaquadrupole instruments where sequential CID
were performed in the two collision cells [14, 15].
Alternatively, pseudo-MS3 experiments can also be
achieved with a triple quadrupole mass spectrometer
equipped with an electrospray ionization (ESI) source.
All ions produced in the ESI source, without any mass
pre-selection, can be collisionally dissociated in the NS
region of the source (pseudo-MS2) [16–18] which can
then undergo further CID in the collision cell of the
triple quadrupole instrument (pseudo-MS3). Since a
triple quadrupole instrument can be operated in three
MS/MS modes, there are three possible pseudo-MS3
modes of operation, viz., NS/product ion MS/MS [19,
20], NS/neutral loss MS/MS [21] and NS/precursor ion
MS/MS [21, 22]. The NS/product ion MS/MS mode is
useful for determining the genetic relationship between
a series of fragment ions while the NS/neutral loss
MS/MS and NS/precursor ion MS/MS modes are both
useful for determining the genetic origin of fragment
ions. In this paper, we focus on the NS/precursor ion
MS/MS experiment since information can often be
obtained directly on the sequences of linear molecules,
including biopolymers.
The pseudo-MS3 experiment in the NS/precursor
ion MS/MS mode, when performed on a triple quad-
rupole instrument equipped with an ESI source, in-
volves three steps. The first step is the fragmentation of
the molecular ion in the ESI source region by NS CID.
The fragment ions then enter the first stage (Q1) of the
triple quadrupole which scans the individual fragment
ions into the second stage collision cell (Q2) for further
CID. The third stage (Q3) is tuned to select a product
ion containing a terminal residue. The first and third
stages of the mass spectrometer are set up in the
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precursor ion MS/MS mode where ion selection and
detection occur at the third stage but the scan function
is determined by the first stage. Thus, a molecular ion is
fragmented into a series of product ions which consec-
utively undergo further fragmentation. However, only
ions related to the selected terminal group are detected
selectively.
Using the NS/precursor ion MS/MS mode, Leh-
mann [21] demonstrated that simplified fragment ion
spectra of peptides can be generated from which se-
quence information can be extracted easily. Selective
Y0-series (C-terminal fragment ions) and B-series (N-
terminal fragment ions) spectra were generated for
individual peptides and a simple peptide mixture.
Sequences of amino acid residues for the peptides can
be directly read from the mass differences between
peaks of the same series. Similar results for selected
peptides were reported by Tabei and coworkers [22].
Since oligonucleotides and oligosaccharides having
linear structures both undergo backbone cleavages
analogous to those of peptides, their sequences should
be directly obtained using pseudo-MS3 in the NS/
precursor ion MS/MS mode provided knowledge of a
terminal group is available. Likewise, synthetic com-
pounds produced by the sequential attachment of a
variety of moieties, using either traditional or combina-
torial synthetic strategies, could undergo backbone
cleavages indicative of the sequence of the moieties in
the structure. In this paper, we demonstrate the direct
sequencing of a series of molecules with linear struc-
tures (oligonucleotides, oligosaccharides, and a syn-
thetic pharmaceutical agent) using the NS/precursor
ion MS/MS mode with a triple quadrupole instrument
and discuss, as well, the limitations of the methodology.
Experimental
DNA oligomers, (59)dCGTA(39) (1, MW 1173) and
(59)dCTCGTA(39) (2, MW 1766), were prepared in-
house. Oligosaccharides, lividomycin A (3, MW 761)
and lacto-N-tetraose (4, MW 707), were purchased from
Sigma Chemical Co. (St. Louis, MO 63178, USA). A
linear pharmaceutical, a derivatized sulfonyl amide
hydroxamic acid (5, C23H26N3O5SBr, monoisotopic MW
535), was synthesized in-house. Samples were dissolved
in acetonitrile:water (1:1 v/v) to a final concentration of
;100 pmol/ml.
Electrospray ionization mass spectra were obtained
with a Micromass Quattro I triple quadrupole mass
spectrometer equipped with a Micromass electrospray
source, rf hexapole lens and megaflow gas nebulizer
probe. The capillary sprayer voltage was set to ;3.5 kV,
the high voltage lens set to ;250 V, and the source
temperature was maintained at ;80 °C. Nitrogen was
used for the ESI nebulizer and bath gases, and was
delivered at flow rates of ;10 and ;300 L/hr, respec-
tively. Argon was used as the collision gas at a pressure
of ;1.5 3 1023 mBar. The detector following Q3 was
used in all experiments by tuning lens 6 for optimum
sensitivity.
For each compound analyzed in the NS/precursor
ion MS/MS mode, the instrumental conditions were
optimized by adjusting the cone voltage and the colli-
sion energy in the NS CID and product ion MS/MS
modes, respectively, to maximize the production of
useful fragment ions over the entire measured mass
range. A cone voltage ramp with a negative slope
(decreasing voltage with increasing mass, typically 50 V
at m/z 100 to 20 V at m/z of the molecular ion) [23], as
well as a collision energy voltage ramp with a positive
slope (increasing voltage with increasing mass, typi-
cally 50 V at m/z 100 to 120 V at m/z of the molecular ion)
[21], can often be used to enhance fragmentation of
useful sequence ions in the NS/precursor ion MS/MS
mode. However, in our experiments, the collision en-
ergy and cone voltages were optimized for each indi-
vidual compound studied. The application of collision
energy and cone voltage ramps was not critical for




Oligonucleotides, phosphate linked nucleotide oli-
gomers, have termini referred to as the 59 and 39-ends.
Using the McLuckey fragmentation nomenclature [24],
fragmentation of oligonucleotide ions could generate w,
x, y, and z series of ions from the 39-end, and a, b, c and
d series of ions from the 59-end.
As expected, both the NS CID spectrum (Figure 1a)
and the product ion MS/MS spectrum (Figure 1b) for
(59)dCGTA(39), 1, each in the negative ion mode, are
quite complicated. These spectra contain various frag-
ment ion series from both the 39 and 59-ends, resulting
in overlapping sequence information. The ESI/NS CID
experiment is performed with no preselected parent
ions since the fragmentation occurs in the source. All
ions generated by NS CID can undergo further frag-
mentation in the collision cell. Fragment ions from the
same terminus (39 or 59-ends) can often produce com-
mon terminal residue ions. For example, negative ions
at m/z 330 are identified as a w1
12 ion from the dA
residue at the 39-end (Scheme 1). When the first quad-
rupole was scanned for precursor ions of m/z 330 at the
third quadrupole, the resulting pseudo-MS3 spectrum
obtained is illustrated in Figure 1c. This NS/precursor
ion MS/MS spectrum of m/z 330 provides selective
detection of all precursor ions producing the w1
12 ions
at m/z 330. All possible 39-end fragment ion series (w, x,
y and z ions) may be observed with the exclusion of all
possible 59-end fragment ion series (a, b, c and d ions).
In this example, as illustrated in Scheme 1, principally,
the w-series ions are observed (w4
12: m/z 1172
([M2H]12), w3
12: m/z 963, w2
12: m/z 634, w1
12: m/z 330), as
well as, one member of the y series of ions (y3
12: m/z
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883). By computing the mass differences between de-
tected ions in the NS/precursor ion MS/MS spectrum,
the sequence of dC-dG-dT-dA can be obtained directly.
Results for (59)dCTCGTA(39), 2, are similar to those
for 1. In the NS CID spectrum (Figure 2a) and product
ion MS/MS spectrum (Figure 2b), each acquired in the
negative ion mode, various fragment ions with overlap-
ping sequence information were observed. Using the
NS/precursor ion MS/MS mode, the precursor ion
spectrum for the 39-terminal residue w1
12 ions with m/z
330 is illustrated in Figure 2c. All w-series ions (Scheme
2) were detected selectively, as well as some y-series
ions, generated from w-series ions via loss of HPO3,
enabling the direct sequencing of the oligonucleotide
from the pseudo-MS3 spectrum.
The sequencing of 1 and 2, where each structure
contains a unique terminating residue, suggests that
similar results can be achieved for unknown DNA and
RNA oligonucleotides. Upon the appearance of known
Figure 1. Negative ion ESI/MS spectra of (59)dCGTA(39), 1, in (a)
the ESI NS CID mode (cone voltage 75 V); (b) the ESI product ion
MS/MS mode (collision energy 100 eV) of parent ion (M2H)12 at
m/z 1172; (c) the ESI NS/precursor ion MS/MS mode (cone
voltage 75 V; collision energy 100 eV) of precursor ion at m/z 330
(see Scheme 1). Note for panels (a) and (c) the doubly charged ion
(M-2H)2- at m/z 586.
Scheme 1
Figure 2. Negative ion ESI/MS spectra of (59)dCTCGTA(39), 2, in
(a) the ESI NS CID mode (cone voltage 100 V); (b) the ESI product
ion MS/MS mode (collision energy 100 eV) of parent ion
(M2H)12 at m/z 1765; (c) the ESI NS/precursor ion MS/MS mode
(cone voltage 100 V; collision energy 100 eV) of precursor ion at
m/z 330 (see Scheme 2). Note for all panels the doubly charged ion
(M-2H)22 at m/z 883.
Scheme 2
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terminal fragment ions corresponding to any of the four
possible nucleotides, the NS/precursor ion MS/MS
pseudo-MS3 experiment could be automatically trig-
gered to acquire data for sequencing such unknown
oligonucleotides.
Oligosaccharide Sequencing
Oligosaccharides, ether linked sugar oligomers, have ter-
mini referred to as the non-reducing and reducing ends.
Using the nomenclature of Domon and Costello [25],
fragmentation of oligosaccharide molecular ions could
generate A, B, and C series of ions from the non-reducing
end, and X, Y, and Z series of ions from the reducing end.
Lividomycin A, 3, a polysaccharide with four sugar
units and a substituted cyclohexyl group, was used as a
model oligosaccharide to demonstrate the sequencing
strategy as illustrated above for the oligonucleotides. In
the NS CID spectrum (Figure 3a) and product ion
MS/MS spectrum (Figure 3b), each in the positive ion
mode, various fragment ions with overlapping se-
quence information were observed. However, the sugar
sequence of lividomycin A can be retrieved easily by
performing a NS/precursor ion MS/MS (pseudo-MS3)
experiment. As illustrated in Scheme 3, a series of Y ions
were detected selectively as the precursor ions of the
reducing end sugar ion at m/z 146 (Figure 3c). By
coincidence, the second sugar from the reducing end
Figure 3. Positive ion ESI/MS spectra of lividomycin A, 3, in (a)
the ESI NS CID mode (cone voltage 70 V); (b) the ESI product ion
MS/MS mode (collision energy 50 eV) of parent ion (M1H)11 at
m/z 762; (c) the ESI NS/precursor ion MS/MS mode (cone voltage
70 V; collision energy 50 eV) of precursor ion at m/z 146 (see
Scheme 3).
Scheme 3
Figure 4. Positive ion ESI/MS spectra of lacto-N-tetraose, 4, in
(a) the ESI NS CID mode (cone voltage 40 V); (b) the ESI product
ion MS/MS mode (collision energy 28 eV) of parent ion (M2H)1-
at m/z 708; (c) the ESI NS/precursor ion MS/MS mode (cone
voltage 40 V; collision energy 28 eV) of precursor ion at m/z 204
(see Scheme 4). Note for panel (a) the natriated molecular ion
(M1Na)11 at m/z 730.
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produces a fragment ion with the same mass as the
precursor mass at m/z 146 which generates interference
precursor peaks at m/z 163 and 616.
Sequencing of lacto-N-tetraose, 4, was treated in the
same fashion. The NS CID spectrum and the product
ion MS/MS spectrum, each in the positive ion mode,
are illustrated in Figures 4a and b, respectively. Among
all the fragment ions observed, the ion at m/z 204 is
identified to be N-acetyl-a-D-glucosamine, the second
sugar from the non-reducing end. The fragment ion
containing the terminal sugar residue at the non-reduc-
ing end was not observed in the positive ion mode since
N-acetyl-a-D-glucosamine has a higher proton affinity.
The NS/precursor ion MS/MS scan of m/z 204 for
lacto-N-tetraose was performed, which selectively de-
tected the B-series fragment ions and the protonated
molecular ion at m/z 708 (Figure 4c). The mass assign-
ments for the B-series fragment ions observed are
illustrated in Scheme 4. Even though the spectra in
Figures 4b and c are similar, the NS/precursor ion
MS/MS scan confirms that the observed ions are from
the same fragment series. Since the charge retaining
residue ion (m/z 204) is not the terminal group, the
NS/precursor ion MS/MS approach could misassign
the sequence without previous knowledge of the termi-
nal group. This example demonstrates the limitation of
the NS/precursor ion MS/MS methodology which will
be discussed in detail in the Limitations section.
Pharmaceutical Sequencing
Nowadays, pharmaceuticals are often produced by
sequential attachment of a series of moieties, using
either traditional or combinatorial synthetic strategies.
Theoretically, these linear structures could undergo
major backbone cleavages, generating fragment ions
indicative of the sequence of the moieties in the struc-
ture. If the compound has a terminal group that retains
the charge, a NS/precursor ion MS/MS scan of the
terminal fragment ion would selectively detect the ion
series containing moieties of the whole molecule.
A typical pharmaceutical compound, 5, was tested to
demonstrate the NS/precursor ion MS/MS strategy.
The NS CID spectrum and the product ion MS/MS
spectrum, each in the positive ion mode, are illustrated
in Figures 5a and b, respectively. The spectra are not
easily interpreted to yield the sequence of the moieties.
The NS/precursor ion MS/MS scan of m/z 70 generated
the spectrum illustrated in Figure 5c. The mass assign-
ments for the series of ions detected are illustrated in
Scheme 5, indicating backbone cleavages at several
locations. The doublet in the spectrum (Figure 5c) at m/z
503 is the only fragment ion with bromine present. In
addition, note the presence of the ions at m/z 296 in all
three spectra (Figure 5a–c) which is most likely due to
Scheme 4
Figure 5. Positive ion ESI/MS spectra of a pharmaceutical com-
pound, 5, in (a) the ESI NS CID mode (cone voltage 50 V); (b) the
ESI product ion MS/MS mode (collision energy 35 eV) of parent
ion (M1H)11 at m/z 536; (c) the ESI NS/precursor ion MS/MS
mode (cone voltage 50 V; collision energy 35 eV) of precursor ion
at m/z 70 (see Scheme 5).
Scheme 5
850 CHEN ET AL. J Am Soc Mass Spectrom 2001, 12, 846–852
the hydrolysis of the sulfonamide bond. For the NS CID
experiments (Figures 5a and c), this process could have
occurred as a vapor phase reaction in the NS CID region
due to the abundance of water from the HPLC carrier
solvent. However, the appearance of ions at m/z 296 in
the MS/MS experiment (Figure 5b), of much lower
abundance, suggests that this process could also occur
as a gas phase reaction. The water responsible for this
proposed hydrolysis process could have originated in
the collision cell either from the instrument background
or even possibly from a thermally induced Lossen
rearrangement [26, 27] of the hydroxamic acid, 5.
Limitations
The use of the NS/precursor ion MS/MS mode for
sequencing biopolymers and unknown structures has
several restrictions limiting its general utility. First, the
fragment mass of the terminal group has to be known
and the terminal group must retain the charge. In
addition, the mass of the precursor fragment ion must
be a unique fragment mass for the molecule. This
pseudo-MS3 sequencing procedure is most successful
when applied to pure materials with linear structures.
Often, the terminal group is known if the sample is
prepared by digestion. Otherwise, the precursor frag-
ment ions containing the terminal group can be de-
duced from the neutral losses of the parent ion or by
trial and error from the low mass fragment ions ob-
served in the NS CID spectrum or the product ion
MS/MS spectra. The difficulty in identifying the termi-
nal group is relieved if it is derivatized or isotopically
enriched. Nevertheless, after optimizing the nozzle-
skimmer, collision energy, and other instrumental pa-
rameters for each sample, the NS/precursor ion
MS/MS pseudo-MS3 method is a relatively straightfor-
ward and useful technique for determining the se-
quence of non-fragmenting moieties (superatoms)
present in molecules, especially when secondary frag-
mentation reactions are absent or minimized.
Conclusion
The NS/precursor ion MS/MS scan, performed on a
triple quadrupole instrument, has been applied success-
fully to peptide sequencing problems [21, 22]. In this
paper, we demonstrated that this pseudo-MS3 scan can
be useful for the sequencing of oligonucleotides, oligo-
saccharides, and linear pharmaceuticals.
First, two oligonucleotides, (59)dCGTA(39), 1, and
(59)dCTCGTA(39), 2, were shown to yield fragment ions
at m/z 330 upon collision activation in both the nozzle-
skimmer and collision cell regions. The ions at m/z 330
were identified to be associated with dA and a simple
NS/precursor ion MS/MS scan of ions at m/z 330
generated spectra from which the sequences of both
oligonucleotides were retrieved directly. Next, sequenc-
ing of oligosaccharides lividomycin A, 3, and lacto-N-
tetraose, 4, was attempted using the same strategy. For
lividomycin A, a spectrum containing only the precur-
sor ions of the reducing end sugar ion at m/z 146 was
obtained and the sequence revealed. The sequencing of
lacto-N-tetraose was not as straightforward, as that of
lividomycin A, since the fragment ion at m/z 204 was
recognized to be N-acetyl-a-D-glucosamine, the second
sugar from the non-reducing end. A NS/precursor ion
MS/MS scan of m/z 204, in this case, only yielded partial
sequence information. This example demonstrated one of
the limitations that restrict the general use of this pseudo-
MS3 approach. Lastly, the NS/precursor ion MS/MS scan
of m/z 70 for a pharmaceutical compound, 5, successfully
revealed a series of fragment ions corresponding to the
sequence of moieties consistent with the structure.
Although this pseudo-MS3 approach has its limita-
tions, the utility of this method has now been demon-
strated. Experiments of this type can be applied to
many biologically important polymers and pharmaceu-
ticals with a triple quadrupole instrument, yielding
valuable sequence information.
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